The multitarget activity of UniPR1331 possibly contributes to its robust antiangiogenic potential that is retained in vivo in the zebrafish yolk membrane in which angiogenesis is driven by VEGF-releasing tumor cells [46] (Fig. 7d, e). Here, VEGFA is linked to neoplasm.